Determining the origin of different variants associated with familial mediterranean fever by machine-learning.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
08 09 2022
08 09 2022
Historique:
received:
25
02
2022
accepted:
30
08
2022
entrez:
8
9
2022
pubmed:
9
9
2022
medline:
14
9
2022
Statut:
epublish
Résumé
A growing number of familial Mediterranean fever (FMF) patients in Israel do not have a single country of origin for all four grandparents. We aimed to predict the Mediterranean fever gene (MEFV) variant most likely to be found for an individual FMF patient, by a machine learning approach. This study was conducted at the Sheba Medical Center, a referral center for FMF in Israel. All Jewish referrals included in this study carried an FMF associated variant in MEFV as shown by genetic testing performed between 2001 and 2017. We introduced the term 'origin score' to capture the dose and different combinations of the grandparents' origin. A machine learning approach was used to analyze the data. In a total of 1781 referrals included in this study, the p.Met694Val variant was the most common, and the variants p.Glu148Gln and p.Val726Ala second and third most common, respectively. Of 26 countries of origin analyzed, those that increased the likelihood of a referral to carry specific variants were identified in North Africa for p.Met694Val, Europe for p.Val726Ala, and west Asia for p.Glu148Gln. Fourteen of the studied countries did not show a highly probable variant. Based on our results, it is possible to describe an association between modern day origins of the three most common MEFV variant types and a geographical region. A strong geographic association could arise from positive selection of a specific MEFV variant conferring resistance to endemic infectious agents.
Identifiants
pubmed: 36076017
doi: 10.1038/s41598-022-19538-1
pii: 10.1038/s41598-022-19538-1
pmc: PMC9458679
doi:
Substances chimiques
MEFV protein, human
0
Pyrin
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
15206Informations de copyright
© 2022. The Author(s).
Références
J Clin Immunol. 2012 Oct;32(5):922-32
pubmed: 22566169
Front Immunol. 2019 Aug 07;10:1745
pubmed: 31456795
Nature. 2020 May;581(7809):434-443
pubmed: 32461654
Acta Medica (Hradec Kralove). 2014;57(3):97-104
pubmed: 25649364
Semin Arthritis Rheum. 2008 Apr;37(5):334-8
pubmed: 18006045
Medicine (Baltimore). 2012 Nov;91(6):337-343
pubmed: 23111802
Ann Hum Genet. 2020 Nov;84(6):423-430
pubmed: 32818295
Nat Immunol. 2020 Aug;21(8):857-867
pubmed: 32601469
Amyloid. 1999 Mar;6(1):1-6
pubmed: 10211405
Hum Mutat. 2008 Jun;29(6):803-8
pubmed: 18409191
Curr Med Chem. 2014;21(3):261-9
pubmed: 24164192
Arthritis Rheumatol. 2018 Jan;70(1):127-133
pubmed: 28992365
Cell Host Microbe. 2016 Sep 14;20(3):296-306
pubmed: 27569559
Clin Rheumatol. 2021 Aug;40(8):3219-3225
pubmed: 33619627
J Med Genet. 2018 Aug;55(8):530-537
pubmed: 29599418
Clin Rheumatol. 2017 Aug;36(8):1707-1713
pubmed: 28624931
Mol Genet Genomic Med. 2017 Nov;5(6):742-750
pubmed: 29178647
PLoS One. 2008 Apr 30;3(4):e2062
pubmed: 18446216
Semin Arthritis Rheum. 2007 Jun;36(6):397-401
pubmed: 17276496
J Hum Genet. 2009 Jun;54(6):369-71
pubmed: 19373257
Semin Arthritis Rheum. 2005 Jun;34(6):813-8
pubmed: 15942916
Hum Mutat. 2004 Sep;24(3):194-8
pubmed: 15300846
N Engl J Med. 2006 Aug 17;355(7):730-2
pubmed: 16914711
Hum Mutat. 2020 Nov;41(11):1866-1870
pubmed: 32741030
Eur J Hum Genet. 2000 Apr;8(4):307-10
pubmed: 10854115
Hum Genet. 2019 Oct;138(10):1117-1122
pubmed: 31243543
Nucleic Acids Res. 2003 Jan 1;31(1):282-5
pubmed: 12520003
Arthritis Rheum. 2009 Oct 15;61(10):1447-53
pubmed: 19790133